---
title: "Codexis, Inc. (CDXS.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CDXS.US.md"
symbol: "CDXS.US"
name: "Codexis, Inc."
industry: "生命科学工具与服务"
---

# Codexis, Inc. (CDXS.US)

| Item | Detail |
|------|--------|
| Industry | 生命科学工具与服务 |
| Location | 美股市场 |
| Website | [www.codexis.com](https://www.codexis.com) |

## Company Profile

Codexis, Inc. 提供用于治疗制造的酶解决方案，利用其专有的 CodeEvolver 技术平台在美国、加拿大、拉丁美洲、欧洲、中东、非洲、澳大利亚、新西兰、东南亚和中国发现、开发和增强新型酶。该公司开发其专有的 ECO Synthesis 制造平台，以通过酶途径实现 RNAi 治疗药物的大规模生产。它与 Aldevron LLC 和 Pfizer Inc. 签订了许可协议

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:12.000Z

**Overall: D (0.77)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 53 / 62 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -17.87% |  |
| Net Profit YoY | -2.99% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.77 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 106.58M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 52.93M |  |


**Multi Score**: D

#### Profit Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -114.26% | E |
| Profit Margin | -120.82% | E |
| Gross Margin | -89.90% | E |

#### Growth Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -17.87% | E |
| Net Profit YoY | -2.99% | C |
| Total Assets YoY | -16.35% | E |
| Net Assets YoY | -47.49% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -82.77% | D |
| OCF YoY | -17.87% | E |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.39 | C |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 68.91% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Codexis, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "E",
      "indicators": [
        {
          "name": "ROE",
          "value": "-114.26%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-120.82%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "-89.90%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "E",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-17.87%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-2.99%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-16.35%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-47.49%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-82.77%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-17.87%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.39",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "68.91%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | ChromaDex (US.CDXC) | A | A | A | B | B | A |
| 02 | 安捷伦科技 (US.A) | A | C | B | C | C | B |
| 03 | 沃特世 (US.WAT) | A | B | B | C | C | B |
| 04 | 药明生物(ADR) (US.WXXWY) | B | B | D | A | B | B |
| 05 | 西氏医药服务 (US.WST) | B | B | B | B | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.67 | 32/59 | - | - | - |
| PB | 2.77 | 31/59 | 4.37 | 3.94 | 3.32 |
| PS (TTM) | 2.01 | 14/59 | 4.25 | 3.81 | 2.87 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-16T05:00:00.000Z

Total Analysts: **7**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 4 | 57% |
| Overweight | 1 | 14% |
| Hold | 2 | 29% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.18 |
| Highest Target | 11.00 |
| Lowest Target | 2.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/CDXS.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CDXS.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CDXS.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.